Biohaven Ltd. BHVN
12.99
(0.20)
(1.52%)
as of 25 Sep
- Market cap
- $2.0B
- P/E
- 0.0×
Follow BHVN
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
— | — | — | — | 0.00 | 0.00 | — | — | — | — |
P/S ratio |
— | — | — | — | 53.04 | 9.07 | — | — | — | — |
P/FCF ratio |
— | — | — | — | 0.00 | 0.00 | — | — | — | — |
P/Operating CF |
— | — | — | — | 8.14 | (164.16) | — | — | — | — |
P/B ratio |
— | — | — | — | 0.00 | 156.42 | — | — | — | — |
Price to Tangible BV |
— | — | — | — | 0.00 | 364.16 | — | — | — | — |
EV/Sales |
— | — | — | — | 52.75 | 10.14 | — | — | — | — |
EV/EBITDA |
— | — | — | — | 0.00 | 0.00 | — | — | — | — |
EV/Operating CF |
— | — | — | — | (44.18) | (41.60) | — | — | — | — |
EV/FCF |
— | — | — | — | (27.93) | (36.22) | — | — | — | — |
Quick Ratio |
2.97 | 13.94 | 13.53 | 4.79 | 1.71 | 2.05 | 6.07 | 7.13 | 3.17 | 2.75 |
Current Ratio |
3.03 | 14.49 | 13.94 | 4.96 | 2.17 | 2.26 | 6.52 | 7.98 | 3.49 | 3.18 |
Net Debt/EBITDA |
0.38 | 1.22 | 0.66 | 0.14 | 0.77 | 0.34 | 0.83 | 0.89 | 0.55 | 0.11 |
Debt/Assets |
2.20% | 0.00% | 40.69% | 72.04% | 38.93% | 1.97% | 4.62% | 0.00% | 0.00% | 52.92% |
Debt/Equity |
(0.34) | 0.00 | 0.78 | (33.41) | (0.68) | 0.08 | 0.06 | 0.00 | 0.00 | 4.59 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.46 | 0.68 | 0.82 | 0.71 | 0.64 | 0.68 | 0.52 | 0.81 | 0.69 | 0.82 |
Capex/Depreciation |
(5.20) | 0.00 | (0.96) | (5.86) | (613.85) | (0.67) | (4.38) | (0.44) | (0.47) | (0.07) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 289.80% | (320.22%) | (170.33%) | (737.03%) | 59.39% | 119.61% | (198.89%) | (84.44%) | (198.83%) | (310.75%) | |
| (440.53%) | (160.08%) | (110.29%) | (166.74%) | (23.01%) | (51.58%) | (141.89%) | (69.48%) | (150.03%) | (138.54%) | |
ROIC |
0.00% | (13,367.54%) | (3,004.63%) | 0.00% | 0.00% | 0.00% | (515.93%) | (590.46%) | 0.00% | 0.00% |
Return on Tangible Assets |
(395.04%) | (107.42%) | (93.00%) | (195.67%) | (35.41%) | (324.43%) | (110.85%) | (100.98%) | (210.78%) | (275.31%) |
Average Days of Receivables |
— | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.06 | 0.14 | 0.03 | 0.04 | 0.03 | 0.04 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Graham Net Nets |
— | — | — | — | (0.14) | 0.00 | — | — | — | — |
Graham Number |
— | — | — | — | 54.06 | 0.00 | — | — | — | — |
Earnings Yield |
— | — | — | — | (15.21%) | (9.49%) | — | — | — | — |
Free Cash Flow Yield |
— | — | — | — | (3.56%) | (3.09%) | — | — | — | — |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(2.34) | (3.40) | (5.03) | (7.78) | (1.93) | (3.70) | (6.65) | (4.66) | (6.38) | (5.66) |
Capex per Share |
0.00 | (0.02) | (0.11) | (0.08) | (1.12) | (0.02) | (0.14) | (0.04) | (0.04) | (0.01) |
Free Cash Flow per Share |
(2.34) | (3.42) | (5.14) | (7.86) | (3.05) | (3.73) | (6.79) | (4.70) | (6.42) | (5.67) |
Cash per Share |
1.87 | 4.72 | 6.74 | 6.53 | 9.02 | 1.93 | 11.19 | 5.36 | 5.33 | 2.97 |
Shareholders Equity per Share |
(0.14) | 4.74 | 3.85 | (0.15) | (9.96) | 0.88 | 12.04 | 6.01 | 4.64 | 0.48 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(0.14) | 4.74 | 3.85 | (0.15) | (9.96) | 0.88 | 12.04 | 6.01 | 4.64 | 0.48 |
Free Cash Flow |
(29.53) | (95.36) | (201.31) | (381.11) | (120.15) | (146.78) | (303.76) | (334.77) | (586.11) | (610.15) |
Working Capital |
16.09 | 127.24 | 252.81 | 262.11 | 325.80 | 52.89 | 496.95 | 387.02 | 384.25 | 252.40 |
Capital Expenditures |
(0.03) | (0.54) | (4.16) | (3.78) | (44.20) | (0.94) | (6.07) | (3.05) | (3.66) | (0.71) |
Net Current Asset Value |
(4.74) | 121.75 | 133.25 | (23.41) | (475.76) | (12.55) | 463.96 | 357.21 | 346.80 | (31.05) |
EV/EBIT |
— | — | — | — | 0.00 | 0.00 | — | — | — | — |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Price to Operating Income |
— | — | — | — | 0.00 | 0.00 | — | — | — | — |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.19 | 0.00 | 0.70 | 0.08 | 0.01 | 0.11 | 0.08 | 0.40 | 0.45 | 0.62 |
Cash ROIC |
(131.85%) | (36.88%) | (38.15%) | (69.17%) | (36.99%) | (139.90%) | (29.46%) | (43.09%) | (65.95%) | (102.51%) |
Accounts Receivable Turnover |
— | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Average Receivables |
— | — | — | — | 214.00 | 65.01 | 28.03 | 29.70 | 7.92 | — |
Average Payables |
0.41 | 2.73 | 7.74 | 12.41 | 31.27 | 26.63 | 7.74 | 13.14 | 16.80 | 14.84 |
Average Inventory |
— | — | — | — | 60.50 | 60.09 | — | — | — | — |
Average Assets |
14.45 | 86.95 | 218.45 | 317.14 | 515.62 | 414.52 | 401.92 | 587.50 | 564.16 | 533.28 |
Average Common Equity |
(21.97) | 43.47 | 141.45 | 71.75 | (199.81) | (178.75) | 286.73 | 483.37 | 425.71 | 237.75 |
Columns are period end dates